Veeva Systems

Veeva Systems

A cloud-based enterprise software company with a focus on the life sciences industry.It was founded in 2007 and is located in Pleasanton, California.

About

Veeva Systems is a cloud-based software company for the global life sciences industry. Veeva has over 400 customers, including pharmaceutical and biotechnology companies. Founded in 2007, Veeva is a publicly held company headquartered in the San Francisco Bay Area, with offices in Philadelphia, Barcelona, London, Paris, Beijing, Shanghai, and Tokyo.

The company primarily focuses on serving several industries such as cosmetics, consumer goods, chemical, life science, and general business. Their solutions range from quality management to enterprise quality management. Veeva Systems saw an increase in usage during the COVID-19 pandemic, with life sciences and biotechnology companies embracing the software to virtually and remotely conduct business.

Product

The company has various products that offer data, software, and services for the life sciences sector. It has different software and platforms for tasks on topics including clinical, regulatory, quality, safety, medical, and commercial. Its services include consulting, training, and events services.

Funding
Angel

On February 6, 2007 Veeva Systems announced raising $3 million in angel funding from undisclosed investors.

Venture

On June 5, 2008 Veeva Systems announced raising $4 million in ventures funding from Emergence.

Timeline

2019
Veeva Systems Makes Two Acquisitions

The company acquires Crossix and Physicians World.

October 16, 2013
Veeva Systems goes Public

The company makes its public debut on Wall Street.

June 5, 2008
Veeva Systems raises a $4,000,000 venture round from Emergence Capital Partners.
February 6, 2007
Veeva Systems raises a $3,000,000 angel round.
2007
Veeva Systems is Founded

The company is funded by Peter Gassner.

Funding rounds

Funding round
Funding type
Funding round amount (USD)
Funding round date
Investment
Veeva Systems funding round, June 2008
4,000,000
June 5, 2008
2 Results
Results per page:
Page 1 of 1

People

Name
Role
LinkedIn

Kevin Spain

Investor

Nitsa Zuppas

CMO

Peter Gassner

Founder and CEO

Tim Cabral

CFO

Tom Schwenger

President and COO

Further reading

Title
Author
Link
Type
Date

Veeva debuts single app for managing clinical trial data

Joseph Keenan

Web

September 19, 2018

Veeva Systems is a rare bird: A cloud company that's making money as it goes public

Christina Farr

Web

October 16, 2013

Veeva Systems sees product usage increase tenfold as biotech companies race to find COVID-19 cure

Tyler Clifford

Web

March 27, 2020

Documentaries, videos and podcasts

Title
Date
Link

Meet Veeva

June 28, 2017

Companies

Company
CEO
Location
Products/Services

News

Title
Author
Date
Publisher
Description
Research and Markets
March 9, 2021
www.prnewswire.com:443
/PRNewswire/ -- The "Pharmacovigilance and Drug Safety Software Market Forecast to 2027 - COVID-19 Impact and Global Analysis By Software Type; Delivery Mode;...
BioSpace
November 11, 2020
BioSpace
As the need to improve efficiency and speed in trials grows, more than 75 organizations, including six of the top 20 pharmaceutical companies, are unifying clinical information and processes with Veeva Vault CTMS . More emerging biotechs and global organizations have adopted the modern cloud application from Veeva Sys
BioSpace
November 4, 2020
BioSpace
Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company developing novel therapies for the management of central nervous system (CNS) disorders, and Veeva Systems (NYSE: VEEV), today announced a strategic partnership to augment the build of Axsome's Digital-Centric Commercialization (DCCTM) platform.
BioSpace
November 4, 2020
BioSpace
Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company developing novel therapies for the management of central nervous system (CNS) disorders, and Veeva Systems (NYSE: VEEV), today announced a strategic partnership to augment the build of Axsome's Digital-Centric Commercialization (DCCTM) platfor
BioSpace
June 8, 2020
BioSpace
Veeva Systems announced that Brent Bowman will become the company's next chief financial officer. Bowman will assume the role of CFO after a transition period of approximately 90 days with current CFO Tim Cabral, who previously announced his intent to retire and assume a new role as an advisor to Veeva.
BioSpace
May 19, 2020
BioSpace
5 of the top 7 CROs join Vault CDMS CRO partner program to speed the deployment of high-quality clinical trials

References

Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.